Ventricular tachycardia because of myocardial infarction after COVID‐19 vaccination

[...]of the concern of vascular side effects of the vaccine, repeated CAG was arranged. [...]the troponin-I level showed mild elevation (0.16 ng/ml), the D-dimer level is higher than 4 times the upper limit of normal (2.438 μg/ml), and his platelet level decreased from 278 to 110 103/μl. The 12-lead...

Full description

Saved in:
Bibliographic Details
Published inJournal of arrhythmia Vol. 38; no. 5; pp. 824 - 826
Main Authors Lee, Dan‐Ying, Lin, Chin‐Yu, Huang, Shao‐Sung
Format Journal Article
LanguageEnglish
Published Japan John Wiley & Sons, Inc 01.10.2022
John Wiley and Sons Inc
Wiley
Subjects
Coronaviruses
COVID-19 vaccines
COVID‐19
Immunization
Medical imaging
myocardial infarction
Spotlight
vaccine
ventricular tachycardia
Taiwan
vaccine
COVID‐19
ventricular tachycardia
myocardial infarction
Online AccessGet full text

Cover

More Information
Summary:[...]of the concern of vascular side effects of the vaccine, repeated CAG was arranged. [...]the troponin-I level showed mild elevation (0.16 ng/ml), the D-dimer level is higher than 4 times the upper limit of normal (2.438 μg/ml), and his platelet level decreased from 278 to 110 103/μl. The 12-lead electrocardiogram (ECG) showed sinus rhythm with the initiation of ventricular tachycardia and new subtle q waves in lead I and aVL (Figure 2). During admission, enzyme-linked immunosorbent assay (ELISA) of Anti-Human Heparin Platelet Factor 4 (HPF-4) antibody was checked but the result is negative (Optical Density value: 0.229, reference: positive if OD > 0.4).
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1880-4276
1883-2148
DOI:10.1002/joa3.12771